MO
MOTS.US Motus GI Holdings Inc
- Market cap
- USD 1.28K
- P/E
- -
- P/B
- -
- ROE
- -275.6%
- Dividend yield
- 115,818.32%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2024.
Is MOTS.US undervalued?
Graham numberThe Graham number of Motus GI Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Motus GI Holdings Inc fundamental analysis
No fundamental analysis for Motus GI Holdings Inc yet.
Motus GI Holdings Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Motus GI Holdings Inc
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Flo…
Full company profileMotus GI Holdings Inc financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
Motus GI Holdings Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 0.00 | 0.00 | 7.00K | 36.0K | 107K | 98.0K | 391K | 592K | 319K | 256K |
| Gross Profit | -45.0K | -46.0K | 4.00K | -18.0K | -29.0K | -398K | -233K | -204K | -589K | 208K |
| Operating Income | -5.33M | -6.01M | -13.0M | -18.9M | -23.4M | -19.0M | -17.9M | -17.9M | -11.9M | -8.10M |
| EBITDA | -5.91M | -7.87M | -13.2M | -15.6M | -23.4M | -18.8M | -18.1M | -17.3M | -11.2M | - |
| Net Income | -5.99M | -8.02M | -13.2M | -22.3M | -22.6M | -19.6M | -18.9M | -18.1M | -12.9M | -8.45M |
| EPS | -115 | -155 | -383 | -441 | -270 | -183 | -121 | -84 | -16 | -1.62 |
| Balance Sheet | ||||||||||
| Total Assets | 1.72M | 12.2M | 9.17M | 23.0M | 32.3M | 24.1M | 26.1M | 17.6M | 7.22M | 7.07M |
| Total Liabilities | 5.44M | 2.16M | 3.65M | 4.44M | 13.9M | 12.8M | 16.4M | 14.7M | 4.54M | 4.00M |
| Shareholders' Equity | -3.72M | 10.0M | 5.52M | 18.5M | 18.3M | 11.3M | 9.66M | 2.98M | 2.69M | 3.07M |
| Cash & Short-term Investments | 1.29M | 11.6M | 7.02M | 21.1M | 28.7M | 20.8M | 22.6M | 14.0M | 4.96M | 4.94M |
| Total Debt | 4.74M | - | - | - | 8.79M | 8.76M | 12.1M | 11.4M | 2.47M | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | -4.92M | -6.13M | -10.4M | -14.9M | -19.9M | -17.0M | -14.4M | -17.5M | -11.4M | -8.09M |
| Capital Expenditure | 68.0K | 30.0K | 707K | 547K | 468K | 88.0K | 470K | 224K | 104K | 0.00 |
| Free Cash Flow | -4.99M | -6.16M | -11.1M | -15.5M | -20.4M | -17.1M | -14.9M | -17.7M | -11.5M | -8.09M |
| Ratios | ||||||||||
| ROE | - | -80.0% | -239.0% | -120.2% | -123.3% | -173.6% | -195.8% | -607.7% | -478.9% | -275.6% |
| ROA | -349.3% | -65.8% | -144.0% | -97.0% | -70.0% | -81.4% | -72.5% | -102.5% | -178.1% | -119.6% |
| Net Profit Margin | - | - | -188,571.4% | -61,825.0% | -21,115.9% | -19,999.0% | -4,836.6% | -3,055.9% | -4,033.5% | -3,301.6% |
| Debt to Equity | - | - | - | - | 0.48x | 0.78x | 1.25x | 3.84x | 0.92x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Motus GI Holdings Inc dividends
- Dividend yield
- 115,818.32%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2023 | USD 1.48M | 1.83 | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
| 2016 | - | - | - |
| 2015 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:15 on Nov 2, 2023.
Who owns Motus GI Holdings Inc
Top funds holding MOTS.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard Institutional Extnd Mkt Idx Tr | 6.88K | 0.13% | 0.00% | Mar 2024 |
| Fidelity Nasdaq Composite Index | 2.64K | 0.05% | 0.00% | Mar 2024 |
| Fidelity Extended Market Index | 2.00K | 0.04% | 0.00% | Mar 2024 |
| BlackRock Extended Mkt Composite | 1.83K | 0.00% | 0.00% | Sep 2023 |
| Fidelity Series Total Market Index | 183.00 | 0.00% | 0.00% | Mar 2024 |
| Northern Trust Extended Eq Market Idx | 127.00 | 0.00% | 0.00% | Mar 2024 |
| NT Ext Equity Mkt Idx Fd - L | 127.00 | 0.00% | 0.00% | Mar 2024 |
| SSgA U.S. Extended Market Index Class I | 113.00 | 0.00% | -0.88% | Dec 2023 |
| BlackRock Extended Equity Market K | 106.00 | 0.00% | 0.00% | Mar 2024 |
| NT Ext Equity Mkt Idx Fd - NL | 73.00 | 0.00% | 0.00% | Dec 2023 |
| NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 59.00 | 0.00% | 0.00% | Dec 2023 |
| Spartan Total Market Index Pool E | 46.00 | 0.00% | 0.00% | Mar 2024 |
| SSgA U.S. Total Market Index Strategy | 33.00 | 0.00% | -2.94% | Dec 2023 |
| Northern Trust Wilshire 5000 | 14.00 | 0.00% | 0.00% | Mar 2024 |
| NT US Market Cap Idx Fd - L | 14.00 | 0.00% | 0.00% | Dec 2023 |
| Extended Equity Market Fund M | 13.00 | 0.00% | 0.00% | Mar 2024 |
| BNYM Mellon NSL Mkt Completion Fund Inst | 3.00 | 0.00% | 0.00% | Dec 2023 |
| NT Ext Eq Mkt Indx Fd DC Lending Tier 5 | 2.00 | 0.00% | 0.00% | Dec 2023 |
Top institutions holding MOTS.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Armistice Capital, LLC | 119K | 7.69% | +214.85% | Dec 2023 |
| Virtu Financial LLC | 10.4K | 0.67% | 0.00% | Dec 2023 |
| Tower Research Capital LLC | 6.88K | 0.44% | +704.91% | Dec 2023 |
| Advisor Group Holdings, Inc. | 1.90K | 0.12% | +14,530.77% | Dec 2023 |
| BlackRock Inc | 137.00 | 0.01% | -21.26% | Dec 2023 |
| Morgan Stanley - Brokerage Accounts | 43.00 | 0.00% | 0.00% | Dec 2023 |
| Wells Fargo & Co | 7.00 | 0.00% | 0.00% | Dec 2023 |
| CWM, LLC duplicate | 3.00 | 0.00% | 0.00% | Dec 2023 |
| Perceptive Advisors LLC | 0.00 | 0.00% | -100.00% | Dec 2023 |
| Vanguard Group Inc | 0.00 | 0.00% | -100.00% | Dec 2023 |
| Geode Capital Management, LLC | 0.00 | 0.00% | -100.00% | Dec 2023 |
| ROBBINS FARLEY LLC | 0.00 | 0.00% | -100.00% | Dec 2023 |
| Bank of America Corp | 0.00 | 0.00% | -100.00% | Dec 2023 |
Motus GI Holdings Inc company profile
- Company name
- Motus GI Holdings Inc
- Ticker
- MOTS.US
- Exchange
- USA Stocks
- Listed since
- Feb 14, 2018
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 15
- Fiscal year end
- December
- Address
- 1301 East Broward Boulevard, Fort Lauderdale, FL, United States, 33301
- Phone
- 954 541 8000
- Website
- motusgi.com
About Motus GI Holdings Inc
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.
Motus GI Holdings Inc management
3- Ms. Ravit RamCFO & VP of Global Operations · born 1975
- Mr. Elad AmorChief Accounting Officer · born 1984
- Jeff VarsalonePresident & Director